46122
40185
S&P/TSX
15389.60
+96.63
+0.63%
S&P-CDNX
776.66
-1.04
-0.13%
S&P-500
2508.24
+1.59
+0.06%
NASDAQ
6456.0439
-5.2788
-0.0817%
Dow
22412.59
+41.79
(0.19%)
Dollar
0.8102
-0.0009
-0.1110%
Oil
50.29
+0.81
+1.64%
Gold
1297.60
-14.90
-1.14%
Silver
17.105
-0.090
-0.523%


Valeant to sell Obagi

Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a deal to sell its Obagi skin care business to a Hong Kong-based group for US$190 million in cash.

The Quebec-based company, headquartered in Laval, estimates its Obagi Medical Products unit will generate about US$85 million of revenue in 2017.

The buyer is a fund managed by a limited partnership that includes China Regenerative Medicine International and Haitong International Securities Group, both headquartered in Hong Kong.



More Business News

45544
Recent Trending
44548
45201
Castanet Proud Member of RTNDA Canada
45705
Press Room
45751